Latest News about INCY
Recent news which mentions INCY
From Benzinga
Why CTI Biopharma Stock Is Surging Today
May 13, 2022
From Motley Fool
From Benzinga
WHO head censored in China after criticizing zero-COVID policy, and U.S. cases up 52% from two weeks ago
May 11, 2022
From MarketWatch
FDA Approves Lilly and Incyte's OLUMIANT (baricitinib) for Hospitalized Patients with COVID-19
May 11, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
3 Nasdaq Stocks to Buy Now for Growth
May 01, 2022
From InvestorPlace
EMA's Advisory Committee Backs Approval Of Incyte's Capmatinib In Advanced Lung Cancer Setting
April 22, 2022
From Benzinga
From Benzinga
Incyte's Ruxolitinib Shows Further Improvement In Facial, Total Body Re-pigmentation At 52 Weeks In Skin Disorder
March 28, 2022
Tickers
INCY
From Benzinga
Incyte-Lilly's Olumiant Continue To Show Improved Scalp, Eyebrows, Eyelash Hair Regrowth At 52 Weeks
March 28, 2022
From Benzinga
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
March 24, 2022
From Motley Fool
From Benzinga
From Benzinga
This Dividend Growth Stock Is a Screaming Buy
March 15, 2022
From Motley Fool
Insiders Buy More Than $80M Of 3 Stocks
March 11, 2022
From Benzinga
Why Are Company Insiders Buying These 7 S&P 500 Stocks?
March 08, 2022
From Benzinga
From MarketWatch
From Benzinga
CTI BioPharma's Bone Marrow Cancer Drug Scores FDA Approval
March 01, 2022
From Benzinga
Insiders Buying Incyte And 2 More Stocks
February 23, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.